At a glance
- Originator Pfizer
- Mechanism of Action Serotonin 1B receptor agonists; Serotonin 1D receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Migraine
Most Recent Events
- 22 Mar 2000 A study has been added to the therapeutic trials section
- 04 Dec 1998 Discontinued-II for Migraine in USA (Unknown route)
- 04 Dec 1998 Discontinued-II for Migraine in United Kingdom (Unknown route)